Alyeska Investment Group’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,102,552
Closed -$3.97M 720
2021
Q4
$3.97M Sell
3,102,552
-148,775
-5% -$298K 0.05% 319
2021
Q3
$7.35M Sell
3,251,327
-2,215,154
-41% -$7.96M 0.09% 254
2021
Q2
$31.1M Sell
5,466,481
-841,116
-13% -$5.6M 0.36% 81
2021
Q1
$39.7M Buy
6,307,597
+242,063
+4% +$1.82M 0.51% 45
2020
Q4
$47.6M Buy
6,065,534
+3,565,534
+143% +$31.5M 0.67% 27
2020
Q3
$25.4M Buy
+2,500,000
New +$25.8M 0.39% 78

Other funds holding TLMD

Alyeska Investment Group's TLMD Position: Q1 2022 in Review

Alyeska Investment Group sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q1 2022, closing a stake of 3,102,552 shares — an estimated $3.97M sold.

Alyeska Investment Group first reported a position in TLMD in Q3 2020 and held it in 6 quarters. The position peaked at $47.6M in Q4 2020. 80 funds tracked by Wall St. Rank hold TLMD as of Q1 2022.

  • Alyeska Investment Group reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 3,102,552 SOC Telemed, Inc. Class A Common Stock shares in Q1 2022, an estimated $3.97M.
  • Alyeska Investment Group first reported a position in SOC Telemed, Inc. Class A Common Stock in Q3 2020 and held it in 6 quarters.
  • Alyeska Investment Group's SOC Telemed, Inc. Class A Common Stock position peaked at $47.6M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q1 2022.

Based on Alyeska Investment Group's 13F filing for Q1 2022, filed 16 May 2022.